Laman UtamaMEHCQ • OTCMKTS
add
23andMe Holding Co.
Tutup sebelumnya
$1.17
Julat hari
$1.07 - $1.18
Julat tahun
$0.48 - $12.76
Permodalan pasaran
30.85J USD
Bilangan Purata
8.09J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Hasil | 60.26J | 34.67% |
Perbelanjaan pengendalian | 65.06J | -22.18% |
Pendapatan bersih | -53.04J | 80.92% |
Margin untung bersih | -88.01 | 85.83% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -21.80J | 62.70% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 79.35J | -67.27% |
Jumlah aset | 277.42J | -54.39% |
Jumlah liabiliti | 214.70J | -7.06% |
Jumlah ekuiti | 62.72J | — |
Syer tertunggak | 26.83J | — |
Harga kepada buku | 0.50 | — |
Pulangan pada aset | -21.15% | — |
Pulangan pada modal | -42.49% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -53.04J | 80.92% |
Tunai daripada operasi | -44.65J | -270.23% |
Tunai daripada pelaburan | 887.00K | 144.09% |
Tunai daripada pembiayaan | -19.00K | -118.10% |
Perubahan bersih dalam tunai | -43.79J | -213.47% |
Aliran tunai bebas | -20.18J | -469.10% |
Perihal
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Diasaskan
Apr 2006
Tapak web
Pekerja
571